"Hyperaldosteronism" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.
Concept/Terms
Conn Syndrome- Conn Syndrome
- Syndrome, Conn
- Primary Hyperaldosteronism
- Hyperaldosteronism, Primary
- Conn's Syndrome
- Conns Syndrome
- Syndrome, Conn's
Below are MeSH descriptors whose meaning is more general than "Hyperaldosteronism".
Below are MeSH descriptors whose meaning is more specific than "Hyperaldosteronism".
This graph shows the total number of publications written about "Hyperaldosteronism" by people in Harvard Catalyst Profiles by year, and whether "Hyperaldosteronism" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 1 | 0 | 1 |
| 1996 | 2 | 0 | 2 |
| 1997 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 0 | 1 |
| 2004 | 3 | 1 | 4 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 1 | 2 |
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 2 | 1 | 3 |
| 2012 | 4 | 0 | 4 |
| 2013 | 1 | 1 | 2 |
| 2014 | 2 | 0 | 2 |
| 2015 | 5 | 0 | 5 |
| 2016 | 1 | 0 | 1 |
| 2017 | 10 | 0 | 10 |
| 2018 | 5 | 0 | 5 |
| 2019 | 3 | 0 | 3 |
| 2020 | 13 | 0 | 13 |
| 2021 | 9 | 0 | 9 |
| 2022 | 10 | 0 | 10 |
| 2023 | 0 | 1 | 1 |
Below are the most recent publications written about "Hyperaldosteronism" by people in Profiles.
-
Aldosterone and Treatment-Resistant Hypertension. N Engl J Med. 2023 Feb 02; 388(5):464-467.
-
Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: a meta-analysis. Eur J Endocrinol. 2022 Dec 01; 187(6):S47-S58.
-
Intrinsic Adrenal TWIK-Related Acid-Sensitive TASK Channel Dysfunction Produces Spontaneous Calcium Oscillations Sufficient to Drive AngII (Angiotensin II)-Unresponsive Hyperaldosteronism. Hypertension. 2022 11; 79(11):2552-2564.
-
Adrenal surgery for bilateral primary aldosteronism: an international retrospective cohort study. Lancet Diabetes Endocrinol. 2022 11; 10(11):769-771.
-
Cortisol-producing adenoma-related somatic mutations in unilateral primary aldosteronism with concurrent autonomous cortisol secretion: their prevalence and clinical characteristics. Eur J Endocrinol. 2022 Oct 01; 187(4):519-530.
-
Primary aldosteronism - a multidimensional syndrome. Nat Rev Endocrinol. 2022 11; 18(11):665-682.
-
Association of cardiovascular disease risk and changes in renin levels by mineralocorticoid receptor antagonists in patients with primary aldosteronism. Hypertens Res. 2022 09; 45(9):1476-1485.
-
Morphologically Normal-Appearing Adrenal Glands as a Prevalent Source of Aldosterone Production in Primary Aldosteronism. Am J Hypertens. 2022 06 16; 35(6):561-571.
-
Autonomous cortisol secretion is associated with worse arterial stiffness and vascular fibrosis in primary aldosteronism: a cross-sectional study with follow-up data. Eur J Endocrinol. 2022 Jun 07; 187(1):197-208.
-
Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study. Hypertension. 2022 09; 79(9):1984-1993.